
Inflammatix
Developer of molecular diagnostics tests designed to interpret the immune system to diagnose acute infections and assess illness severity. The company's tests measure specific messenger RNA markers in...
Valuation
$0
Share Price
N/A
Total Raised
$213.5M
Last Round
N/A